MCT4 inhibitor (Phenex Pharmaceuticals)

N/A

Report date: 2025/01/26 16:25:20
NME

Base Information

Drug NameMCT4 inhibitor (Phenex Pharmaceuticals)
Drug Alias NameMCT4 inhibitors (Phenex Pharmaceutical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonocarboxylate transporter 4 inhibitors
TargetsMonocarboxylate transporter 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhenex Pharmaceuticals Ag
China Registration ClassN/A

Develop Information

Active CompaniesPhenex Pharmaceuticals Ag
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A